申请人:Abbott Laboratories
公开号:US06166013A1
公开(公告)日:2000-12-26
Compounds having Formula I ##STR1## are useful for modulating the glucocorticoid receptor in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula I and methods of treating immune, autoimmune, inflammatory, adrenal imbalance, cognitive and behavioral diseases in a mammal.
具有化学式I的化合物对于调节哺乳动物体内的糖皮质激素受体具有用处。还公开了包括化学式I化合物的药物组合物以及治疗哺乳动物的免疫、自身免疫、炎症、肾上腺失调、认知和行为疾病的方法。